| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.062 | 20.049 | 16.557 | 15.120 | 19.147 | 109.957 | 210.165 | 219.690 | 226.837 | 265.643 |
| Total Income - EUR | 24.062 | 20.049 | 16.557 | 15.120 | 19.153 | 115.027 | 210.583 | 222.270 | 226.837 | 266.233 |
| Total Expenses - EUR | 24.126 | 16.724 | 12.420 | 18.240 | 65.395 | 74.727 | 106.190 | 122.141 | 135.244 | 177.094 |
| Gross Profit/Loss - EUR | -64 | 3.325 | 4.138 | -3.120 | -46.242 | 40.300 | 104.393 | 100.129 | 91.593 | 89.139 |
| Net Profit/Loss - EUR | -64 | 2.791 | 4.138 | -3.120 | -46.434 | 39.283 | 102.291 | 97.959 | 89.325 | 81.169 |
| Employees | 3 | 4 | 2 | 4 | 2 | 4 | 4 | 3 | 4 | 5 |
Check the financial reports for the company - Dana Gyn Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 42.388 | 32.154 | 28.677 | 22.005 | 143.537 | 182.774 | 144.904 | 112.269 | 258.425 | 206.959 |
| Current Assets | 499 | 618 | 307 | 285 | 687 | 3.854 | 16.803 | 11.147 | 26.543 | 53.242 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 30 | 0 | 711 | 0 | 0 | 0 | 48.126 |
| Cash | 499 | 618 | 307 | 255 | 687 | 3.142 | 16.803 | 11.147 | 26.543 | 5.117 |
| Shareholders Funds | -36.969 | -33.801 | -29.091 | -31.677 | -77.498 | -36.745 | 66.361 | 98.014 | 89.403 | 81.230 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 61 | 60 |
| Debts | 79.856 | 66.572 | 58.075 | 53.968 | 221.721 | 223.372 | 95.345 | 25.401 | 195.565 | 178.971 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dana Gyn Med Srl